Search research articles
Contact Us
Filters
Showing results (191-200 of 225) with videos related to
Page
of 23
Sort By:
Journal of Cardiovascular Pharmacology
|
October 2, 2024
Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa study
Antonio Abbate, Benjamin Van Tassell, Vlad Bogin, et al.
European Heart Journal
|
May 10, 2018
The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA
Paul C Cremer, Yiran Zhang, Maria Alu, et al.
Journal of Cardiovascular Pharmacology
|
December 6, 2024
Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study
Antonio Abbate, Benjamin Van Tassell, Vlad Bogin, et al.
JACC. Heart Failure
|
September 16, 2019
The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
Klaus K Witte, Janusz Lipiecki, Tomasz Siminiak, et al.
Annals of Vascular Surgery
|
May 11, 2023
Value of Routine Troponin Measurement in Open Abdominal Aortic Aneurysm Repair
Cole C Pickney, Casey C Kuka, Kogulan Nadesakumaran, et al.
Clinical Cardiology
|
August 25, 2020
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)
Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, et al.
Open Heart
|
December 15, 2022
Imaging and haemodynamic parameters associated with clinical outcomes following isolated tricuspid valve surgery
Essa Hariri, Habib Layoun, Jonathan Hansen, et al.
Journal of Cardiovascular Development and Disease
|
January 27, 2026
Comparison of Diastolic Function Parameters After Alcohol Septal Ablation and Mavacamten Therapy in Obstructive Hypertrophic Cardiomyopathy
Danish Saleh, Ellis Y Kim, Kifah Hussain, et al.
Circulation. Cardiovascular Interventions
|
July 16, 2021
Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial
Paul C Cremer, Tom Kai Ming Wang, L Leonardo Rodriguez, et al.
European Heart Journal. Imaging Methods and Practice
|
July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis
Paul C Cremer, David Lin, Sushil A Luis, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 225) with videos related to
Sort By:
Page
of 23
Journal of Cardiovascular Pharmacology
|
October 2, 2024
Interleukin-1 blockade with RPH-104 (goflikicept) in patients with ST-segment elevation myocardial infarction (STEMI): secondary endpoints from an international, double blind, randomized, placebo-controlled, phase IIa study
Antonio Abbate, Benjamin Van Tassell, Vlad Bogin, et al.
European Heart Journal
|
May 10, 2018
The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA
Paul C Cremer, Yiran Zhang, Maria Alu, et al.
Journal of Cardiovascular Pharmacology
|
December 6, 2024
Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study
Antonio Abbate, Benjamin Van Tassell, Vlad Bogin, et al.
JACC. Heart Failure
|
September 16, 2019
The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation
Klaus K Witte, Janusz Lipiecki, Tomasz Siminiak, et al.
Annals of Vascular Surgery
|
May 11, 2023
Value of Routine Troponin Measurement in Open Abdominal Aortic Aneurysm Repair
Cole C Pickney, Casey C Kuka, Kogulan Nadesakumaran, et al.
Clinical Cardiology
|
August 25, 2020
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)
Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, et al.
Open Heart
|
December 15, 2022
Imaging and haemodynamic parameters associated with clinical outcomes following isolated tricuspid valve surgery
Essa Hariri, Habib Layoun, Jonathan Hansen, et al.
Journal of Cardiovascular Development and Disease
|
January 27, 2026
Comparison of Diastolic Function Parameters After Alcohol Septal Ablation and Mavacamten Therapy in Obstructive Hypertrophic Cardiomyopathy
Danish Saleh, Ellis Y Kim, Kifah Hussain, et al.
Circulation. Cardiovascular Interventions
|
July 16, 2021
Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial
Paul C Cremer, Tom Kai Ming Wang, L Leonardo Rodriguez, et al.
European Heart Journal. Imaging Methods and Practice
|
July 24, 2024
Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis
Paul C Cremer, David Lin, Sushil A Luis, et al.
Page
of 23